Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,577,575
+$522,809 QoQ
Shares Held
2,149
-3.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#2,266
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TIEMANN INVESTMENT ADVISORS, LLC holds $9,289,456 across 7 Drug Manufacturers - General names. LLY ranks #2 (27.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,451 | $2,654,240 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
2,149 | $2,577,575 | |
| 3 | ABBV |
AbbVie Inc.
|
9,227 | $2,321,882 | |
| 4 | MRK |
Merck & Co., Inc.
|
6,492 | $834,222 | |
| 5 | AMGN |
Amgen Inc
|
1,119 | $405,212 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,122 | $268,093 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,961 | $228,232 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,577,575 | 2,149 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $2,054,766 | 2,234 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,933,349 | 1,799 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,378,741 | 1,807 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,435,894 | 1,842 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,521,326 | 1,842 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,418,164 | 1,837 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,654,049 | 1,867 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,792,652 | 1,980 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,561,365 | 2,007 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,155,347 | 1,982 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,074,797 | 2,001 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $938,897 | 2,002 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $684,092 | 1,992 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $697,656 | 1,907 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $576,209 | 1,782 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $592,368 | 1,827 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $499,715 | 1,745 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $472,336 | 1,710 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $406,648 | 1,760 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $415,431 | 1,810 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $340,012 | 1,820 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $321,302 | 1,903 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $281,682 | 1,903 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $316,539 | 1,928 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $221,813 | 1,599 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||